BTN2A1 and cranioectodermal dysplasia: Secondly, BTN2A1 variants may predispose patients to CeD, via BTN2A1’s role as a ligand for DC-SIGN on DCs, which are important in CD pathogenesis in presenting gluten antigens to CD4+ αβ T cells [24,25].